Oral vinorelbine in young patients with desmoid-type fibromatosis,Tumori Journal

当前位置： X-MOL 学术 › Tumori J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Oral vinorelbine in young patients with desmoid-type fibromatosis
Tumori Journal ( IF 1.9 ) Pub Date : 2023-04-28 , DOI: 10.1177/03008916231169806
Laure Kornreich ₁ , Daniel Orbach ₂ , Nayla Nicolas ₃ , Hervé J Brisse ₃ , Pablo Berlanga ₄ , Anne-Sophie Defachelles ₅ , Ludovic Mansuy ₆ , Cécile Verite ₇ , Laure Saumet ₈ , Marie Karanian _{9,

10} , Nadège Corradini ₁

Affiliation

Department of Pediatric Hematology and Oncology-IHOPe, Léon Bérard Center, Lyon, France.
SIREDO Oncology Center Care- Innovation and Research for Children and AYA with Cancer- PSL Research University, Institut Curie, Paris, Île-de-France, France.
Imaging Department, Institut Curie, Paris, Île-de-France, France.
Gustave Roussy Cancer Campus, Department of Children and Adolescents Oncology, Villejuif, Île-de-France, France.
Pediatric oncology department, Oscar Lambret center, Lille, Hauts-de-France, France.
Children's University Hospital, Department of Pediatric Hematology and Oncology, Nancy, France.
Pediatric Hematology Department, Bordeaux University Hospital, Bordeaux, Aquitaine, France.
Department of Pediatric Onco-Hematology, University Hospital of Montpellier, Montpellier, Languedoc-Roussillon, France.
Department of Biopathology, Léon Bérard Center, Lyon, Rhône-Alpes, France.
Université Claude Bernard Lyon 1, Université Lyon, Cancer Research Center of Lyon, France.

Background:Desmoid-type fibromatosis are rare intermediate tumors in children and adolescents. Owing to local aggressiveness and relapse, systemic treatment for symptomatic advanced or progressive ...

中文翻译：